Press release
Thyroid Eye Disease Market Poised to Grow at 8.5% CAGR, Reaching USD 3.0 Billion by 2034
Thyroid Eye Disease Market
Thyroid Eye Disease (TED), also known as thyroid-associated ophthalmopathy or orbitopathy, is an autoimmune condition that affects the tissues around the eyes. Closely linked to Graves' disease, TED is characterized by inflammation, swelling, double vision, and in severe cases, sight-threatening complications due to optic nerve compression. The disorder has a profound impact on quality of life, requiring multidisciplinary management by endocrinologists and ophthalmologists.
The global Thyroid Eye Disease (TED) Market is undergoing a paradigm shift as new biologic therapies offer targeted solutions. The approval of Teprotumumab (Tepezza) marked a breakthrough, providing the first disease-modifying therapy for moderate-to-severe TED. Combined with growing awareness, increasing prevalence of autoimmune thyroid conditions, and expanding clinical research, the TED market is poised for robust growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72240
Market Overview
• Market Size (2024): Estimated at USD 1.3 billion
• Forecast (2034): Expected to reach USD 3.0 billion
• CAGR (2024-2034): Projected at 8.5%
Key Growth Drivers
• Rising global prevalence of autoimmune thyroid disorders.
• Breakthrough biologic therapies transforming treatment paradigms.
• Improved diagnosis and awareness campaigns by patient advocacy groups.
• Increasing collaboration between endocrinology and ophthalmology specialists.
Key Challenges
• High cost of biologics restricting accessibility in low- and middle-income countries.
• Long-term safety and efficacy data for newer therapies still evolving.
• Limited awareness and delayed diagnosis in emerging regions.
• Lack of standardized treatment protocols across geographies.
Leading Players
Horizon Therapeutics (Amgen), Roche, Novartis, Sanofi, AbbVie, Teva Pharmaceuticals, Alexion (AstraZeneca), and emerging biotech firms innovating in immune modulation and ophthalmology.
Segmentation Analysis
By Treatment Type
• Corticosteroids (First-line for acute inflammation)
• Immunosuppressants (Methotrexate, Azathioprine)
• Biologics (Teprotumumab, Rituximab, Tocilizumab)
• Orbital Radiotherapy
• Surgical Interventions (Orbital Decompression, Strabismus Surgery, Eyelid Repair)
• Symptomatic Care (Lubricants, Eye Shields)
By Route of Administration
• Intravenous
• Oral
• Subcutaneous
• Topical (adjunctive)
By Disease Severity
• Mild TED
• Moderate-to-Severe TED
• Sight-Threatening TED
By End User
• Hospitals
• Specialty Ophthalmology & Endocrinology Clinics
• Ambulatory Surgical Centers
• Academic & Research Institutes
Segmentation Summary
Corticosteroids remain widely used, but biologics are the fastest-growing treatment class, offering disease-modifying potential. Surgical interventions continue to play a role in advanced TED, while supportive therapies ensure symptomatic relief across all stages.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72240/thyroid-eye-disease-market
Regional Analysis
North America
• 2024 Market Size: USD 600 million
• 2034 Forecast: USD 1.4 billion
• CAGR: 8.4%
The U.S. dominates with early biologic adoption, strong healthcare infrastructure, and significant patient advocacy presence.
Europe
• 2024 Market Size: USD 400 million
• 2034 Forecast: USD 900 million
• CAGR: 8.3%
Germany, the U.K., and France lead adoption, supported by reimbursement frameworks and clinical research centers.
Asia-Pacific
• 2024 Market Size: USD 230 million
• 2034 Forecast: USD 610 million
• CAGR: 9.7%
China, Japan, and India show rapid growth due to rising thyroid disorder prevalence and expanding biologics availability.
Middle East & Africa
• 2024 Market Size: USD 40 million
• 2034 Forecast: USD 90 million
• CAGR: 8.2%
Saudi Arabia, UAE, and South Africa are building thyroid and ophthalmology care capacity, though biologic access remains limited.
Latin America
• 2024 Market Size: USD 30 million
• 2034 Forecast: USD 70 million
• CAGR: 8.0%
Brazil and Mexico dominate regional adoption with improving healthcare access and research collaborations.
Regional Summary
North America leads in biologics adoption, but Asia-Pacific is the fastest-growing market, driven by large patient populations and healthcare system modernization.
Market Dynamics
Key Growth Drivers
• Increasing global burden of thyroid-associated autoimmune disease.
• Expanding role of Teprotumumab and other biologics in disease modification.
• Growing investment in multidisciplinary care models.
• Rising patient awareness and demand for quality-of-life improvements.
Key Challenges
• Accessibility barriers due to biologic pricing.
• Long-term efficacy and safety monitoring of new treatments.
• Lack of uniform treatment guidelines globally.
• Underdiagnosis in low-resource regions.
Latest Trends
• Expanding clinical trials of Rituximab and Tocilizumab for refractory TED.
• Development of biosimilars and cost-effective biologics to improve access.
• Integration of AI-driven diagnostic imaging to monitor disease activity.
• Increasing role of patient advocacy groups in shaping treatment standards.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72240
Competitor Analysis
Key Companies
• Horizon Therapeutics (Amgen) - Market leader with Tepezza, the first FDA-approved biologic for TED.
• Roche - Active in immunotherapy development for autoimmune diseases.
• Novartis - Expanding pipeline in ophthalmology and immunology.
• Sanofi - Advancing biologics targeting inflammatory pathways.
• AbbVie - Strong immunology portfolio with ophthalmic relevance.
• Teva Pharmaceuticals - Providing corticosteroids and supportive therapies.
• Alexion (AstraZeneca) - Leader in rare autoimmune and inflammatory diseases.
Competitive Dynamics
The TED market is consolidating around biologics innovation, with Horizon's Tepezza setting the benchmark. However, competition is intensifying as Roche, Novartis, and Sanofi expand their pipelines. Biosimilar development and pricing strategies will play a crucial role in future market access.
Conclusion
The Thyroid Eye Disease (TED) Market is expected to grow from USD 1.3 billion in 2024 to USD 3.0 billion by 2034, at a CAGR of 8.5%.
Opportunities Ahead
• Development of biosimilars and next-gen biologics to expand accessibility.
• Growth in Asia-Pacific patient pool due to rising thyroid disease incidence.
• Integration of AI and imaging technologies for early detection.
• Expansion of multidisciplinary care models globally.
Key Takeaways
• TED is closely tied to Graves' disease and autoimmune thyroid disorders.
• Biologics, particularly Tepezza, are transforming treatment paradigms.
• North America and Europe dominate today, but Asia-Pacific offers the strongest growth potential.
• Affordability and innovation will shape the competitive landscape over the next decade.
This report is also available in the following languages : Japanese (甲状腺眼疾患市場), Korean (갑상선 안구 질환 시장), Chinese (甲状腺眼病市场), French (Marché des maladies oculaires liées à la thyroïde), German (Markt für Schilddrüsenaugenerkrankungen), and Italian (Mercato delle malattie degli occhi della tiroide), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72240
Our More Reports:
Hyperglycemia Market
https://exactitudeconsultancy.com/reports/72028/hyperglycemia-market
Homozygous Familial Hypercholesterolemia Market
https://exactitudeconsultancy.com/reports/72026/homozygous-familial-hypercholesterolemia-market
HIVassociated Lipodystrophy Market
https://exactitudeconsultancy.com/reports/72024/hivassociated-lipodystrophy-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Eye Disease Market Poised to Grow at 8.5% CAGR, Reaching USD 3.0 Billion by 2034 here
News-ID: 4192290 • Views: …
More Releases from Exactitude Consultancy
Adult Myopia Market Forecast to Grow at 7.6% CAGR, Reaching USD 40.2 Billion by …
Introduction
Myopia, or nearsightedness, is one of the most common refractive errors worldwide, affecting both children and adults. In adults, untreated or progressive myopia can lead to significant vision impairment, increased risk of retinal detachment, glaucoma, and myopic macular degeneration. Driven by lifestyle changes such as increased screen exposure, reduced outdoor activity, and urbanization, the prevalence of adult myopia is growing at an unprecedented rate.
The Adult Myopia Market is positioned for…
Optic Neuritis Market Expected to Grow at 8.0% CAGR, Reaching USD 2.6 Billion by …
Introduction
Optic neuritis is an inflammatory condition of the optic nerve that often leads to sudden vision loss, eye pain, and impaired color vision. It is frequently associated with autoimmune and demyelinating disorders such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). While many patients experience partial recovery, recurrent or severe cases may result in long-term vision impairment.
The Optic Neuritis Market is gaining global significance as research advances in…
Neurotrophic Keratitis Market Poised for Significant Growth at 8.1% CAGR, Expect …
Introduction
Neurotrophic keratitis (NK) is a rare, degenerative corneal disease caused by impaired corneal innervation, leading to reduced healing capacity, persistent epithelial defects, and potential corneal ulceration or perforation. It is often secondary to conditions such as herpes simplex infection, diabetes, trigeminal nerve injury, or ocular surgeries. Left untreated, NK can result in permanent vision loss.
Historically, management options were limited to supportive care such as lubricants, tarsorrhaphy, or amniotic membrane transplantation.…
Myopic Macular Degeneration Market to Grow at 8.0% CAGR by 2034
Introduction
Myopic Macular Degeneration (MMD), also referred to as myopic maculopathy or pathological myopia, is a progressive retinal condition that occurs in individuals with high myopia. Characterized by degeneration of the macula, choroidal neovascularization, and retinal atrophy, MMD is a leading cause of irreversible vision loss in working-age adults, particularly in East Asia.
The rapid rise in global myopia prevalence-driven by urbanization, lifestyle changes, and increased screen time-has dramatically expanded the patient…
More Releases for USD
Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements
Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and…
Bamboo Clothing Market: USD 1.83B to USD 3.27B by 2030
Bamboo Clothing Market Poised for Robust Growth with Sustainability and Eco-Friendly Trends Driving Demand
The global bamboo clothing market is experiencing substantial growth, spurred by a significant shift towards sustainable fashion and eco-friendly materials. As consumers become increasingly conscious of their environmental impact, bamboo fabric-known for its natural, biodegradable properties-is gaining popularity in the fashion industry. This market is expected to continue its upward trajectory, driven by rising demand for eco-conscious…
Biometrics Market: "Biometrics: USD 34.3B to USD 112.4B by 2031"
Biometrics Market Market Scope:
Key Insights : Biometrics Market size was valued at USD 34.3 billion in 2022 and is poised to grow from USD 39.1 billion in 2023 to USD 112.4 billion by 2031, growing at a CAGR of 14.1% during the forecast period (2024-2031).
Discover Your Competitive Edge with a Free Sample Report :https://www.skyquestt.com/sample-request/biometrics-market
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/biometrics-market
In-Depth Exploration of the global Biometrics…
Advanced (3D/4D) Visualization Systems Market Size, Trends, Growth, Share to sur …
Fatpos Global has carefully studied specific areas, such as application and product type, in the global Advanced (3D/4D) Visualization Systems Market research study. During the predicted period of 2022 to 2032, each kind gives data on sales. The Advanced (3D/4D) Visualization Systems Market analysis examines into the characteristics and financials of the leading participants.
As per the analysis research report, the Advanced (3D/4D) Visualization Systems Market to…
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com.
There is a $3,000,000…
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa."
These days many businesses are adopting a market research report…
